Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Aug;32(8):2375-2390.
doi: 10.1007/s11136-023-03400-6. Epub 2023 Apr 4.

Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves

Claudia A Bargon  1   2 , Dieuwke R Mink van der Molen  3 , Marilot C T Batenburg  3 , Lilianne E van Stam  3 , Iris E van Dam  4 , Inge O Baas  5 , Liesbeth M Veenendaal  6 , Wiesje Maarse  7 , Maartje Sier  8   9 , Ernst J P Schoenmaeckers  10 , Josephina P J Burgmans  11 , Rhodé M Bijlsma  5 , Femke van der Leij  4 , Annemiek Doeksen  8 , Danny A Young-Afat  12 , Helena M Verkooijen  13   14
Affiliations
Multicenter Study

Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves

Claudia A Bargon et al. Qual Life Res. 2023 Aug.

Abstract

Purpose: During the first SARS-CoV-2-infection wave, a deterioration in emotional well-being and increased need for mental health care were observed among patients treated or being treated for breast cancer. In this follow-up study, we assessed patient-reported quality of life (QoL), physical functioning, and psychosocial well-being during the second SARS-CoV-2-infection wave in a large, representative cohort.

Methods: This longitudinal cohort study was conducted within the prospective, multicenter UMBRELLA breast cancer cohort. To assess patient-reported QoL, physical functioning and psychosocial well-being, COVID-19-specific surveys were completed by patients during the first and second SARS-CoV-2-infection waves (April and November 2020, respectively). An identical survey was completed by a comparable reference population during the second SARS-CoV-2-infection waves. All surveys included the validated EORTC-QLQ-C30/BR23, HADS and "De Jong-Gierveld Loneliness" questionnaires. Pre-COVID-19 EORTC-QLQ-C30/BR23 and HADS outcomes were available from UMBRELLA. Response rates were 69.3% (n = 1106/1595) during the first SARS-CoV-2-infection wave and 50.9% (n = 822/1614) during the second wave. A total of 696 patients responded during both SARS-CoV-2-infection waves and were included in the analysis comparing patient-reported outcomes (PROs) during the second SARS-CoV-2-infection wave to PROs during the first wave. Moreover, PROs reported by all patients during the second SARS-CoV-2-infection wave (n = 822) were compared to PROs of a similar non-cancer reference population (n = 241) and to their pre-COVID-19 PROs.

Results: Patient-reported QoL, physical functioning, and psychosocial well-being of patients treated or being treated for breast cancer remained stable or improved from the first to the second SARS-CoV-2-infection wave. The proportion of emotional loneliness reduced from 37.6 to 29.9% of patients. Compared to a similar non-cancer reference population, physical, emotional, and cognitive functioning, future perspectives and symptoms of dyspnea and insomnia were worse in patients treated or being treated for breast cancer during the second SARS-CoV-2-infection wave. PROs in the second wave were similar to pre-COVID-19 PROs.

Conclusion: Although patients scored overall worse than individuals without breast cancer, QoL, physical functioning, and psychosocial well-being did not deteriorate between the first and second wave. During the second wave, PROs were similar to pre-COVID-19 values. Overall, current findings are cautiously reassuring for future mental health of patients treated or being treated for breast cancer.

Keywords: Breast cancer; COVID-19; Corona virus; Longitudinal; Mental health; Pandemic; Patient-reported outcomes; Psychosocial well-being; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial or personal conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
Flowchart of included patients treated or being treated for breast cancer from the prospective, multicenter ‘Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluAtion’ (UMBRELLA)
See this image and copyright information in PMC

References

    1. World Health Organization (WHO). (2020, Mar 11). WHO director-general’s opening remarks at the media briefing on COVID-19. Retrieved July 19, 2021, from https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
    1. Ludwigson A, Huynh V, Myers S, Hampanda K, Christian N, Ahrendt G, Romandetti K, Tevis S. Patient perceptions of changes in breast cancer care and well-being during COVID-19: A mixed methods study. Annals of Sugical Oncology. 2022;29(3):1649–57. doi: 10.1245/s10434-021-11209-1. - DOI - PMC - PubMed
    1. Bargon CA, Batenburg MCT, van Stam LE, van der Molen DRM, van Dam IE, van der Leij F, Baas IO, Ernst MF, Maarse W, Vermulst N, Schoenmaeckers EJP, van Dalen T, Bijlsma RM, Young-Afat DA, Doeksen A, Verkooijen HM. Impact of the COVID-19 pandemic on patient-reported outcomes of breast cancer patients and survivors. JNCI Cancer Spectrum. 2021;5(1):pkaa104. doi: 10.1093/jncics/pkaa104. - DOI - PMC - PubMed
    1. van de Poll-Franse LV, de Rooij BH, Horevoorts NJE, May AM, Vink GR, Koopman M, van Laarhoven HWM, Besselink MG, Oerlemans S, Husson O, Beijer S, Ezendam NPM, RaijmakersWollersheim NJM BM, Hoedjes M, Siesling S, van Eenbergen MC, Mols F. Perceived care and well-being of patients with cancer and matched norm participants in the COVID-19 crisis: Results of a survey of participants in the Dutch PROFILES registry. JAMA Oncology. 2021;7(2):279–284. doi: 10.1001/jamaoncol.2020.6093. - DOI - PMC - PubMed
    1. Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic. JAMA. 2020;323(20):2005–2006. doi: 10.1001/jama.2020.6236. - DOI - PubMed

Publication types